Manufacturer record
Lars Medicare Private Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Lars Medicare Private Limited (Haryana) were declared Not of Standard Quality between February 2022 and March 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 201061, Intravenous Infusion Set (exp Apr 2025). RDTL Guwahati (state lab) found it not of standard quality: Description, kinking of the tubing & Leakage Test. Listed in the March 2022 alert.
Records by type
2 records linked to Lars Medicare Private Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Intravenous Infusion Set | Batch 201061Mfg May 2020 · Exp Apr 2025 | Description, kinking of the tubing & Leakage TestDescription | RDTL GuwahatiState lab | Mar 2022 |
| Intravenous Infusion Set | Batch 201047Mfg May 2020 · Exp Apr 2025 | Kinking of the tubingOther | RDTL GuwahatiState lab | Feb 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.